Results 31 to 40 of about 100,852 (314)
European Journal of Medical Research, 2011 Major progress for the management of invasive aspergillosis has come from the introduction of new antifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%.
Karthaus M
doaj +1 more source
Aspergillus fumigatus and Aspergillosis in 2019
Clinical Microbiology Reviews, 2019 Aspergillus fumigatus is a saprotrophic fungus; its primary habitat is the soil. In its ecological niche, the fungus has learned how to adapt and proliferate in hostile environments. This capacity has helped the fungus to resist and survive against human
J. Latgé, Georgios Chamilos
semanticscholar +1 more source
Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity
Mycoses (Berlin), 2020 Information on the recently COVID‐19‐associated pulmonary aspergillosis (CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU patients with coronavirus disease 2019 (COVID‐19), and review the published literature from ...
M. Machado +15 more
semanticscholar +1 more source
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2020 Chronic pulmonary aspergillosis (CPA) is a disease which is diffcult to diagnose and which complicates other respiratory diseases. Forms of CPA include chronic cavitary pulmonary aspergillosis, chronic fbrosing pulmonary aspergillosis, simple ...
Demidik S. N. +5 more
doaj +1 more source
Aspergillosis Complicating Severe Coronavirus Disease
Emerging Infectious Diseases, 2020 Aspergillosis complicating severe influenza infection has been increasingly detected worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has been detected through rapid reports, primarily from centers in Europe.
K. Marr +6 more
semanticscholar +1 more source
Journal of Infectious Diseases, 2021 Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening superinfection of severe respiratory viral infections, such as influenza.
F. Lamoth +3 more
semanticscholar +1 more source
Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients [PDF]
, 2013 Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients
Klingebiel, Thomas +3 more
core +2 more sources
Mycoses (Berlin), 2020 Invasive aspergillosis is a well‐known complication of severe influenza pneumonia with acute respiratory distress syndrome (ARDS). However, recent studies are reporting emergence of aspergillosis in severe COVID‐19 pneumonia, named as COVID‐19‐associated
N. Nasir +3 more
semanticscholar +1 more source
Diagnostic and Interventional Imaging, 2015 Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L. +5 more
openaire +3 more sources
Immunodiagnosis of aspergillosis [PDF]
Clinical Microbiology Reviews, 1991 Aspergillus species are ubiquitous fungi and have been implicated as the causative agents of a variety of lung disorders in humans. These disorders include allergic, saprophytic, and systemic manifestations. The allergic disorders mainly affect atopic persons, and invasive or systemic diseases affect immunosuppressed individuals.
V. K. Kurup, Anoopa Kumar
openaire +3 more sources